Literature DB >> 21788779

Missed opportunities for tuberculosis prevention in New York City, 2003.

Meredith E Slopen1, Fabienne Laraque, Amy S Piatek, Shama D Ahuja.   

Abstract

BACKGROUND: Proper management and prevention can radically decrease the incidence of tuberculosis (TB). To further decrease TB cases in New York City, every opportunity for prevention must be utilized. This study sought to identify patients whose disease could have been prevented and describe missed opportunities for TB prevention.
METHODS: Patients diagnosed with TB from April to July, 2003 were identified using the New York City TB registry. Surveillance data, medical records, and patient interviews were used to determine whether patients missed a prevention opportunity or potential for screening. Preventable TB was defined as inappropriate screening of contacts and immigrants, inappropriate treatment of persons with prior TB diagnoses, or those who tested positive for latent TB infection (LTBI) as contacts, immigration, or in community settings. Potentially preventable TB was defined as occurring when those eligible for LTBI screening in community settings were not screened more than 1 year before TB diagnosis. Patients classified as having preventable or potentially preventable TB were grouped as patients with missed opportunities. We calculated the odds of missing a prevention opportunity using logistic regression.
RESULTS: Among the 218 study patients, 22% had preventable TB and 35% had potentially preventable TB. The most common missed opportunity among patients with preventable TB was the failure to initiate LTBI treatment. Birth outside of the United States was not associated with missing a prevention opportunity (odds ratio [OR] = 1.31, confidence interval [CI] = 0.71-2.39); however, extended travel outside of the United States increased the odds (OR = 2.51, CI = 1.19-5.69), particularly among non-US-born patients (OR = 3.01, CI = 1.21-8.59). Missed screening opportunities related to pregnancy, employment, or school attendance were encountered by over half of the study patients.
CONCLUSIONS: The majority of New York City TB patients in our cohort experienced at least 1 missed opportunity for prevention. Further study is warranted to determine whether LTBI treatment eligibility should be extended to those who travel for extended periods, particularly among the non-US-born patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788779     DOI: 10.1097/PHH.0b013e31820759b8

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  6 in total

1.  Disparities in tuberculosis burden among South Asians living in New York City, 2001-2010.

Authors:  Natalie Stennis; Lisa Trieu; Bianca Perri; Janelle Anderson; Muhammad Mushtaq; Shama Ahuja
Journal:  Am J Public Health       Date:  2014-11-13       Impact factor: 9.308

Review 2.  Extensively drug-resistant tuberculosis in a young child after travel to India.

Authors:  Nicole Salazar-Austin; Alvaro A Ordonez; Alice Jenh Hsu; Jane E Benson; Mahadevappa Mahesh; Elizabeth Menachery; Jafar H Razeq; Max Salfinger; Jeffrey R Starke; Aaron M Milstone; Nicole Parrish; Eric L Nuermberger; Sanjay K Jain
Journal:  Lancet Infect Dis       Date:  2015-11-16       Impact factor: 25.071

3.  Pediatric and adolescent tuberculosis in the United States, 2008-2010.

Authors:  Carla A Winston; Heather J Menzies
Journal:  Pediatrics       Date:  2012-11-26       Impact factor: 7.124

4.  Risk of Adverse Infant Outcomes Associated with Maternal Tuberculosis in a Low Burden Setting: A Population-Based Retrospective Cohort Study.

Authors:  Sylvia M LaCourse; Sharon A Greene; Elizabeth E Dawson-Hahn; Stephen E Hawes
Journal:  Infect Dis Obstet Gynecol       Date:  2016-02-16

5.  Contemporary Social Disparities in TB Infection and Disease in the USA: a Review.

Authors:  Grace A Noppert; Ryan E Malosh; Elizabeth B Moran; Shama D Ahuja; Jon Zelner
Journal:  Curr Epidemiol Rep       Date:  2018-09-28

Review 6.  Latent Tuberculosis in Pregnancy: A Systematic Review.

Authors:  Isabelle Malhamé; Maxime Cormier; Jordan Sugarman; Kevin Schwartzman
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.